3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Glioblastoma
40
Breast Neoplasms
23
Gliosarcoma
22
Esophageal Neoplasms
21
Prostatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
19
Pancreatic Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Rectal Neoplasms
13
Glioma
13
Brain Neoplasms
13
Uterine Cervical Neoplasms
12
Neoplasms
12
Lung Neoplasms
11
Head and Neck Neoplasms
11
Melanoma
10
Astrocytoma
10
Sarcoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Central Nervous System Neoplasms
8
Stomach Neoplasms
7
Lymphoma, Follicular
6
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Adenocarcinoma Of Esophagus
6
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Carcinoma
5
Burkitt Lymphoma
5
Interventions
pembrolizumab
3
Ipilimumab
2
Blood Specimen Collection
2
spartalizumab
1
necitumumab
1
mirdametinib
1
leronlimab
1
apatinib
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Rosuvastatin Calcium
1
Radiotherapy
1
Radiation
1
Positron-Emission Tomography
1
PankoMab-GEX
1
Panitumumab
1
Nivolumab
1
Metformin
1
Magnetic Resonance Imaging
1
MEK inhibitor I
1
Jupiter
1
JPT1 protein, human
1
Interleukin-2
1
Immune Checkpoint Inhibitors
1
GAT
1
Fluorodeoxyglucose F18
1
FCN-437c
1
EBI-005
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Solid Tumor, Adult
×
Radiation
×
Clear all
NCT03728179
2024-02-20
RACIN
Centre Hospitalier Universitaire Vaudois
Phase 1
Completed
40 enrolled